Upmc Cancercenter

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Bladder cancer1 trial
• Cervical cancer1 trial
• Gastric and oesophageal cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Mesothelioma1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Chimagen Biosciences, Ltd1 trial
• Incyte Corporation1 trial

Closed trials

• Terminated

  First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

  NCT05348889· Phase 1/2· Chimagen Biosciences, Ltd· Source

• Completed

  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

  NCT04242199· Phase 1· Incyte Corporation· Source